Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods

被引：18

作者：

Benson, Lyndsey S. ^{[1
]}

Micks, Elizabeth A. ^{[1
]}

机构：

[1] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2015年 / 42卷 / 04期

关键词：

Combined hormonal contraception; Combined oral contraceptive pills; Extended contraceptive use; Continuous contraceptive use; Ovulation suppression; Bleeding profile with contraception; Contraceptive vaginal ring; Contraceptive transdermal patch; CYCLIC ORAL-CONTRACEPTIVES; LEVONORGESTREL/ETHINYL ESTRADIOL; BLEEDING PROFILE; VAGINAL RING; OPEN-LABEL; PILL; FREQUENCY; SAFETY; ACCEPTABILITY; ENDOMETRIOSIS;

D O I：

10.1016/j.ogc.2015.07.009

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Combined hormonal contraceptives (CHCs) have traditionally been prescribed in 28-day cycles, with 21 days of active hormones followed by a 7-day hormone-free interval. Extended and continuous CNC regimens, defined as regimens with greater than 28 days of active hormones, offer many benefits, including a decrease in estrogen-withdrawal symptoms and likely greater efficacy because of more reliable ovulation suppression. Bleeding profiles are favorable, and unscheduled bleeding decreases over time with these regimens. Extended and continuous regimens of combined oral contraceptives and the contraceptive vaginal ring are safe and have high user acceptability and satisfaction. However, despite numerous benefits, extended and continuous CHC regimens are underused.

引用

页码：669 / +

页数：15

共 42 条

[21] MONITORING OF ADVERSE REACTIONS TO DRUGS IN UNITED-KINGDOM [J].

INMAN, WHW .

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1970, 63 (12) :1302-&

[22] Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study [J].

Jensen, Jeffrey T. ;

Garie, Sona Grossova ;

Trummer, Dietmar ;

Elliesen, Joerg .

CONTRACEPTION, 2012, 86 (02) :110-118

[23]

Jones Jo, 2012, Natl Health Stat Report, P1

[24] Menstruation: choosing whether ... and when [J].

Kaunitz, AM .

CONTRACEPTION, 2000, 62 (06) :277-284

[25] Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen [J].

Klipping, Christine ;

Duijkers, Ingrid ;

Trummer, Dietmar ;

Marr, Joachim .

CONTRACEPTION, 2008, 78 (01) :16-25

[26] Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study [J].

Klipping, Christine ;

Duijkers, Ingrid ;

Fortier, Michel P. ;

Marr, Joachim ;

Trummer, Dietmar ;

Elliesen, Joerg .

JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2012, 38 (02) :84-93

[27]

Krishnan S, 2010, INT J WOMENS HEALTH, V2, P235

[28] ACCEPTABILITY OF AN ORAL-CONTRACEPTIVE THAT REDUCES FREQUENCY OF MENSTRUATION - TRI-CYCLE PILL REGIMEN [J].

LOUDON, NB ;

FOXWELL, M ;

POTTS, DM ;

GUILD, AL ;

SHORT, RV .

BRITISH MEDICAL JOURNAL, 1977, 2 (6085) :487-490

[29] Extended regimens of the contraceptive vaginal ring - A randomized trial [J].

Miller, L ;

Verhoeven, CHJ ;

in't Hout, J .

OBSTETRICS AND GYNECOLOGY, 2005, 106 (03) :473-482

[30] Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: A randomized trial [J].

Miller, L ;

Hughes, JP .

OBSTETRICS AND GYNECOLOGY, 2003, 101 (04) :653-661

← 1 2 3 4 5 →